HEB : Summary for Hemispherx BioPharma, Inc. Comm - Yahoo Finance

Canadian Markets closed

Hemispherx Biopharma, Inc. (HEB)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.69-0.05 (-7.13%)
At close: 4:02PM EST
People also watch
GNBTCVMBCRXCTICVICL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.74
Open0.74
Bid0.00 x
Ask0.00 x
Day's Range0.68 - 0.74
52 Week Range0.65 - 2.64
Volume526,949
Avg. Volume110,362
Market Cap16.63M
Beta-1.21
PE Ratio (TTM)-1.53
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire10 days ago

    Hemispherx Biopharma Announces Extension of Rintatolimod European Early Access Program (EAP) to Pancreatic Cancer Patients

    PHILADELPHIA, Jan. 11, 2017-- Hemispherx Biopharma announced today that the rintatolimod European early access program designed to enable access of the compound to ME/CFS patients has been extended to ...

  • Capital Cube18 days ago

    ETFs with exposure to Hemispherx Biopharma, Inc. : January 3, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Hemispherx Biopharma, Inc. Here are 5 ETFs with the largest exposure to HEB-US. Comparing the performance and risk of Hemispherx Biopharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Hemispherx Biopharma, Inc. : December 8, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Hemispherx Biopharma, Inc. Here are 5 ETFs with the largest exposure to HEB-US. Comparing the performance and risk of Hemispherx Biopharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)